Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted

Silexion Therapeutics Corp

1-for-10 reverse share split effective after close May 28; shares trade on split-adjusted basis May 29 under ticker SLXN.
Authorized shares reduced to 5.9M; par value increased to $0.135 per share.
Each warrant now exercisable for 1/10 share at $15,525.00 per whole share (was $1,552.50).
Shareholders approved reverse split at reconvened EGM on May 5, 2026.
Split intended to maintain compliance with Nasdaq minimum bid price requirement.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

Silexion Therapeutics Corp: On May 28, 2026, the Company filed a certificate amending its Amended and Restated Memorandum of Association to effect a 1-for-10 reverse share split, increasing par value from $0.0135 to $0.135 per share and reducing issued and outstanding ordinary shares proportionately (effective 2026-05-28).

Change: charter amendment
Effective: 2026-05-28

Exact text from the filing

On May 28, 2026, the Company’s Board of Directors, acting pursuant to that approval by the Company’s shareholders, effected the Reverse Share Split following the close of trading on the Nasdaq Capital Market through the filing of a certificate with the Companies Registry of the Cayman Islands that served as an effective amendment to the Company’s Amended and Restated Memorandum of Association (the “ Memorandum Amendment ”).

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Silexion Therapeutics Corp filing history →

Source: SEC EDGAR

accession 0001178913-26-002988

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.